JACK DODD: Open Payments
NPI 1417942434 · AMES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$112 in 6 payments from 4 companies in 2025. Trend: 2023 $202 · 2024 $490 · 2025 $112
Food & beverage: $112
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
Products named: ARISTADA, ABILIFY ASIMTUFII, INGREZZA, LOREEV XR.
Industry payments across IA — which companies pay providers there.
